A short review of a recent online course by Reaktor, Gesund Partners and University of Helsinki on the topic of Value-based Healthcare. Some of the concepts are highly relevant for the industry and call for a transformative shift.

On July 29th, 2020, two new Brazilian pharmacovigilance regulations, the resolution RDC 406/2020 and normative instruction IN 63/2020, were published by Anvisa. What are the most significant changes brought by these two new documents?

Your daily routine can be a lot easier if you’re able to adopt some simple tools that are widely accessible at a low cost today. Our experience with tools such as Power Automate, Zapier or Butler might help you to make your workday more effective.

On July 6th, EMA and HMA released a joint strategy for the next five years for a 2-month public consultation. What comments did we share with the authorities?